Breaking news

CING Joins Pan-European PoCCardio Initiative to Revolutionize Heart Attack Prediction

The Cyprus Institute of Neurology and Genetics (CING) has become an integral partner in the European PoCCardio research project, an ambitious initiative designed to enhance the prediction and prevention of myocardial infarctions. This collaboration unites premier research institutions from across the continent in a bid to develop refined, individualised diagnostic tools for cardiovascular disease.

Project Overview And Funding

Titled Personalised Medicine by Using an Advanced Point-Of-Care Tool for Stratified Treatment In High Risk Cardiovascular Patients, the project is set to enroll 1,800 patients with a history of heart attacks in clinical trials. These trials focus on collecting essential medical data and biomarker measurements, thereby advancing diagnostic accuracy and prognostic assessment for heart conditions. The initiative is backed by a robust €14 million budget from the European Union’s Horizon Europe programme, with CING securing €540,000 to support its contribution.

Strategic Partnership And Expertise

CING has joined PoCCardio under the Horizon Europe “Hop-on Facility,” part of the program’s Widening Participation and Spreading Excellence initiative. This move allows research institutions from developing countries to engage in forefront research and innovation. Leading the institute’s contribution, the Department of Bioinformatics, well-versed in computational diagnostics and therapeutics, operates under the expert guidance of Associate Scientist Dr Anastasios Oulas. Dr Oulas emphasized that modern bioinformatics is key to predicting myocardial infarction risks, enabling timely, personalised treatments for patients.

Bridging Technical And Clinical Expertise

Professor Hans Peter Dimai, the project coordinator from the Medical University of Graz, hailed CING’s participation. He highlighted the role of CING’s Department of Bioinformatics as a crucial bridge between clinical experience and technical innovation, particularly through Systems Bioinformatics, which is essential for predicting high-risk patients and refining treatment responses.

Innovative Diagnostic Integration

Within the PoCCardio framework, CING’s team will harness advanced network generation tools to map clinically significant interactions among biomarkers. This process involves creating complex networks from genomic and proteomic data alongside publicly available datasets detailing proteins and gene polymorphisms linked to cardiovascular conditions. The resulting algorithms will bolster the prediction of myocardial infarction risks. Furthermore, the department aims to develop a diagnostic protocol that integrates enriched biomarker measurements with data from a point-of-care device, thus streamlining rapid and cost-effective analysis using state-of-the-art artificial intelligence.

Advancing European Research Excellence

CING’s engagement in PoCCardio not only cements its role as a key player in cutting-edge European research but also reinforces Horizon Europe’s overarching mission to enhance innovation and research excellence across the continent. The collaborative efforts promise to yield significant advancements in cardiovascular patient care and diagnostic services.

EU E-Commerce VAT Systems Generate €257.9 Million Revenue for Cyprus in 2024

Robust Revenue Growth Through Streamlined VAT Collection

Cyprus has demonstrated a significant fiscal boost in 2024 with €257.9 million generated from the European Union’s e-commerce VAT systems, according to Tax Commissioner Sotiris Markides. This impressive performance underscores the effectiveness of the One Stop Shop (OSS) and Import One Stop Shop (IOSS) frameworks in simplifying cross-border tax compliance.

Simplified Procedures for EU and Non-EU Businesses

The OSS system allows Cyprus-registered businesses to streamline VAT declaration and payment on sales to consumers in other EU countries. Companies simply register on the local OSS platform, apply the consumer’s VAT rate, aggregate their submissions quarterly or monthly, and remit a single consolidated payment. Subsequently, Cyprus allocates the appropriate share to each respective EU country. This efficient process extends to non-EU sellers as well, who can have their intra-EU distance sales managed under the Union Scheme.

Breakdown of VAT Revenue Streams

Last year’s declarations under the various schemes illustrate the system’s broad reach: €217.9 million was collected via the Union Scheme, €36.9 million through the Non-Union Scheme, and €3.1 million via the Import Scheme. While the Union Scheme caters to both EU and non-EU sellers engaging in distance sales, the Non-Union Scheme specifically accommodates non-EU firms delivering services to EU consumers. Furthermore, the Import Scheme targets goods valued at less than €150 that are imported from outside the EU.

Implications and Broader Impact

Implemented in July 2021 as an evolution from the more limited MOSS system, these reforms have not only consolidated tax collection through an expansive OSS but also integrated the IOSS for low-value imports. By designating certain online marketplaces as “deemed suppliers,” the new framework ensures that VAT collection is both efficient and equitable. Across the EU, these mechanisms have generated over €33 billion in VAT revenues in 2024, reflecting a successful effort to simplify tax compliance, reduce administrative burdens, and promote fair taxation across the bloc.

The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter